These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 26261677)
1. Myxoid dermatofibroma on a great toe: a case report. Moon A; Yoon N; Kim HS Int J Clin Exp Pathol; 2015; 8(6):7605-9. PubMed ID: 26261677 [TBL] [Abstract][Full Text] [Related]
2. Subungual Acral Fibromyxoma Involving the Bone: A Mimicker of Malignancy. Carranza C; Molina-Ruiz AM; Pérez de la Fuente T; Kutzner H; Requena L; Santonja C Am J Dermatopathol; 2015 Jul; 37(7):555-9. PubMed ID: 25062265 [TBL] [Abstract][Full Text] [Related]
3. Superficial Acral Fibromyxoma: Report of 13 Cases With New Immunohistochemical Findings. Cullen D; Díaz Recuero JL; Cullen R; Rodríguez Peralto JL; Kutzner H; Requena L Am J Dermatopathol; 2017 Jan; 39(1):14-22. PubMed ID: 28045748 [TBL] [Abstract][Full Text] [Related]
4. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Mentzel T; Schärer L; Kazakov DV; Michal M Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans. Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669 [TBL] [Abstract][Full Text] [Related]
6. Superficial acral fibromyxoma: a clinicopathological and immunohistochemical analysis of 12 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Fanti PA; Dika E; Piraccini BM; Infusino SD; Baraldi C; Misciali C G Ital Dermatol Venereol; 2011 Aug; 146(4):283-7. PubMed ID: 21785394 [TBL] [Abstract][Full Text] [Related]
9. Superficial acral fibromyxoma: clinicopathological, immunohistochemical, and molecular study of 11 cases highlighting frequent Rb1 loss/deletions. Agaimy A; Michal M; Giedl J; Hadravsky L; Michal M Hum Pathol; 2017 Feb; 60():192-198. PubMed ID: 27825811 [TBL] [Abstract][Full Text] [Related]
10. Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma. Calikoglu E; Chavaz P; Saurat JH; Kaya G Dermatology; 2003; 207(1):104-6. PubMed ID: 12835568 [TBL] [Abstract][Full Text] [Related]
11. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors. Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036 [TBL] [Abstract][Full Text] [Related]
12. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Fetsch JF; Laskin WB; Miettinen M Hum Pathol; 2001 Jul; 32(7):704-14. PubMed ID: 11486169 [TBL] [Abstract][Full Text] [Related]
13. Superficial acral fibromyxoma: report of two cases. Kazakov DV; Mentzel T; Burg G; Kempf W Dermatology; 2002; 205(3):285-8. PubMed ID: 12399679 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous balloon cell dermatofibroma (fibrous histiocytoma). Tran TA; Hayner-Buchan A; Jones DM; McRorie D; Carlson JA Am J Dermatopathol; 2007 Apr; 29(2):197-200. PubMed ID: 17414448 [TBL] [Abstract][Full Text] [Related]